Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1997;95:1487-1496

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cooper, R. A. S.
Right arrow Articles by Wharton, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cooper, R. A. S.
Right arrow Articles by Wharton, J. M.

(Circulation. 1997;95:1487-1496.)
© 1997 American Heart Association, Inc.


Articles

Internal Atrial Defibrillation in Humans

Improved Efficacy of Biphasic Waveforms and the Importance of Phase Duration

Randolph A. S. Cooper, MD; Eric E. Johnson, MD; J. Marcus Wharton, MD

From the Department of Medicine, Duke University Medical Center, Durham, NC.

Correspondence to Randolph A.S. Cooper, MD, Room B-140, Volker Hall, 1670 University Blvd, University of Alabama at Birmingham, Birmingham, AL 35294-0019. E-mail rac{at}crml.uab.edu.

Background The optimal waveform for internal atrial defibrillation (IAD) in humans is unknown. This study tested the effect of waveform duration and phase duration on the efficacy of biphasic waveforms for IAD.

Methods and Results Electrodes were positioned in the right atrial appendage and coronary sinus in 13 patients. In part 1, the atrial defibrillation thresholds (ADFTs) for 5 monophasic waveforms (2, 4, 6, 10, and 20 ms) and 5 symmetrical biphasic waveforms (1/1, 2/2, 3/3, 5/5, and 10/10 ms) were compared in 6 patients. In part 2, the ADFTs for two asymmetrical biphasic waveforms (7.5/2.5 and 2.5/7.5 ms) were compared with those for a symmetrical biphasic waveform (5/5 ms) and a monophasic waveform (10 ms) in 7 patients. In part 1, biphasics with total durations of 4 to 20 ms had significantly lower ADFTs than monophasic waveforms of the same total duration. For a total duration of 2 ms, there was no significant difference in ADFTs between the biphasic and the monophasic waveforms. There was no difference between symmetrical biphasic waveforms of 4 to 20 ms. In part 2, the 7.5/2.5 ms asymmetrical biphasic had significantly lower ADFTs than the three other waveforms tested. Both the 7.5/2.5 ms asymmetrical and the 5/5 ms symmetrical biphasic waveform had significantly lower ADFTs than the 2.5/7.5 ms asymmetrical biphasic and the 10 ms monophasic waveforms.

Conclusions For IAD in humans, biphasic waveforms were more efficacious than monophasic waveforms. This improved efficacy is related to the total duration of the biphasic waveform and each individual phase duration of the biphasic waveform.


Key Words: defibrillation • atrium • arrhythmia




This article has been cited by other articles:


Home page
EuropaceHome page
S. J. Walsh, G. Manoharan, O. J. Escalona, J. Santos, N. Evans, J. McC. Anderson, M. Stevenson, J. D. Allen, and A.A. J. Adgey
Novel rectangular biphasic and monophasic waveforms delivered by a radiofrequency-powered defibrillator compared with conventional capacitor-based waveforms in transvenous cardioversion of atrial fibrillation.
Europace, October 1, 2006; 8(10): 873 - 880.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S. J. Walsh, D. McCarty, A. J.J. McClelland, C. G. Owens, T. G. Trouton, M. T. Harbinson, S. O'Mullan, A. McAllister, B. M. McClements, M. Stevenson, et al.
Impedance compensated biphasic waveforms for transthoracic cardioversion of atrial fibrillation: a multi-centre comparison of antero-apical and antero-posterior pad positions
Eur. Heart J., July 1, 2005; 26(13): 1298 - 1302.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Manoharan, N. Evans, D. Allen, J. Anderson, and J. Adgey
Comparing the Efficacy and Safety of a Novel Monophasic Waveform Delivered by the Passive Implantable Atrial Defibrillator With Biphasic Waveforms in Cardioversion of Atrial Fibrillation
Circulation, April 6, 2004; 109(13): 1686 - 1692.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
G. Q. Villani, M. F. Piepoli, and A. Capucci
Reproducibility of internal atrial defibrillation threshold in paroxysmal and persistent atrial fibrillation
Europace, January 1, 2004; 6(4): 267 - 272.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J.C. Geller, S. Reek, C. Timmermans, T. Kayser, H.-F. Tse, C. Wolpert, W. Jung, A.J. Camm, C.-P. Lau, H. J.J. Wellens, et al.
Treatment of atrial fibrillation with an implantable atrial defibrillator -- long term results
Eur. Heart J., December 1, 2003; 24(23): 2083 - 2089.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Manoharan, N. Evans, B. Kidwai, D. Allen, J. Anderson, and J. Adgey
Novel Passive Implantable Atrial Defibrillator Using Transcutaneous Radiofrequency Energy Transmission Successfully Cardioverts Atrial Fibrillation
Circulation, September 16, 2003; 108(11): 1382 - 1388.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
G. Lehmann, J. Horcher, K. Dennig, A. Plewan, K. Ulm, and E. Alt
Atrial Mechanical Performance After Internal and External Cardioversion of Atrial Fibrillation : An Echocardiographic Study
Chest, January 1, 2002; 121(1): 13 - 18.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Ammer, G.u. Lehmann, A. Plewan, K. Puetter, and E. Alt
Marked reduction in atrial defibrillation thresholds with repeated internal cardioversion
J. Am. Coll. Cardiol., November 1, 1999; 34(5): 1569 - 1576.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Cooklin, M. R. Olsovsky, R. G. Brockman, S. R. Shorofsky, and M. R. Gold
Atrial defibrillation with a transvenous lead: A randomized comparison of active can shocking pathways
J. Am. Coll. Cardiol., August 1, 1999; 34(2): 358 - 362.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Timmermans, L.-M. Rodriguez, G. M. Ayers, H. Lambert, J. L. R. M. Smeets, J. W. S. Vlaeyen, A. Albert, and H. J. J. Wellens
Effect of Butorphanol Tartrate on Shock-Related Discomfort During Internal Atrial Defibrillation
Circulation, April 13, 1999; 99(14): 1837 - 1842.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. A. S. Cooper, V. J. Plumb, A. E. Epstein, G. N. Kay, and R. E. Ideker
Marked Reduction in Internal Atrial Defibrillation Thresholds With Dual-Current Pathways and Sequential Shocks in Humans
Circulation, June 30, 1998; 97(25): 2527 - 2535.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Schauerte, F. A. Schondube, M. Grossmann, H. Dorge, F. Stein, B. Dohmen, A. Moumen, K. Erena, B. J. Messmer, P. Hanrath, et al.
Influence of Phase Duration of Biphasic Waveforms on Defibrillation Energy Requirements With a 70-µF Capacitance
Circulation, May 26, 1998; 97(20): 2073 - 2078.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. A. Gray and J. Jalife
Effects of Atrial Defibrillation Shocks on the Ventricles in Isolated Sheep Hearts
Circulation, April 28, 1998; 97(16): 1613 - 1622.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. A. S. Cooper, W. M. Smith, and R. E. Ideker
Internal Cardioversion of Atrial Fibrillation : Marked Reduction in Defibrillation Threshold With Dual Current Pathways
Circulation, October 21, 1997; 96(8): 2693 - 2700.
[Abstract] [Full Text]